Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/22894
Full metadata record
DC FieldValueLanguage
dc.creatorR. de Arce
dc.creatorE. Eding
dc.creatorJoão Marques Teixeira
dc.creatorV. Milanova
dc.creatorE. Rancans
dc.creatorB. Ibach
dc.creatorA. Schreiner
dc.date.accessioned2019-02-01T19:04:02Z-
dc.date.available2019-02-01T19:04:02Z-
dc.date.issued2009
dc.identifier.othersigarra:84358
dc.identifier.urihttps://repositorio-aberto.up.pt/handle/10216/22894-
dc.language.isoeng
dc.relation.ispartofPharmacopsychiatry, Vol.42, nº5
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectPsicologia
dc.subjectPsychology
dc.titleDescriptive analysis of the aripiprazole arm in the risperidone long-acting injectable vs. quetiapine relapse prevention trial (constaTRE)
dc.typeResumo de Comunicação em Conferência Internacional
dc.contributor.uportoFaculdade de Psicologia e de Ciências da Educação
dc.subject.fosCiências sociais::Psicologia
dc.subject.fosSocial sciences::Psychology
Appears in Collections:FPCEUP - Resumo de Comunicação em Conferência Internacional

Files in This Item:
File Description SizeFormat 
84358.pdf21.01 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons